{"acknowledgements and funding": 5, "consent": 1, "material y mtodos": 1, "results": 57, "cort regulation of pre- and post-synaptic function": 1, "functional implications of cort-induced increase in nmdar in the adult brain": 1, "appendix 2 functional capacity, physical activity, and well-being questionnaires": 1, "conclusions": 38, "role of gsk-3 in metaplasticity": 1, "symptoms": 1, "data revision": 1, "ghrelin and growth hormone secretagogues": 1, "reference 23": 1, "reference 22": 1, "reference 21": 1, "reference 20": 1, "reference 27": 1, "author details": 51, "reference 25": 1, "reference 24": 1, "demographics": 1, "cort and synaptic plasticity": 1, "background": 52, "clinical implications": 1, "the regulation of gsk3 signaling by akt and cell surface receptors": 1, "table 2": 1, "table 1": 1, "concluding remarks": 1, "resultados": 1, "acknowledgments": 13, "appendix 1 cognitive test battery": 1, "anti-apoptotic actions of ghrelin, des-acylated ghrelin and gh secretagogues": 1, "cardiac biomarkers and echocardiographic findings": 1, "possible mechanisms of cort-induced changes in nmdar in the adult brain": 1, "convergence of actions, multiple hits, and target selectivity": 1, "methods": 45, "authors information": 1, "evidence for a role of akt and gsk3 signaling in the behavioral effects of lithium": 1, "gsk-3, ltd, and the implications for learning and memory": 1, "reference 4": 1, "downstream effectors of gsk-3 in synaptic plasticity": 1, "endnotes": 1, "results and discussion": 1, "gsk3, mglurs, and synaptic plasticity": 1, "conclusions and future perspectives": 1, "contribuciones de autora": 1, "funding": 3, "discusin": 1, "animal models of fxs": 1, "reference 3": 1, "method": 2, "ethnic differences": 1, "limitations": 1, "pre-publication history": 28, "potential targets of gsk3 that may contribute to fxs abnormalities": 1, "a role for cb2rs in neuropsychiatric disorders": 1, "acknowledgement and funding": 1, "ghrelin receptor": 1, "introduccin": 1, "clinical trials registration": 1, "glycogen synthase kinase-3": 1, "fragile x syndrome etiology and pathology": 1, "title": 1, "what does the study add to the literature": 1, "reference 18": 1, "reference 19": 1, "reference 16": 1, "reference 17": 1, "reference 14": 1, "reference 15": 1, "reference 12": 1, "reference 13": 1, "reference 10": 1, "reference 11": 1, "trigger event": 1, "role in synaptic plasticity at gabaergic synapses": 1, "references": 78, "reference 9": 1, "hippocampal cognitive development and maternal care": 1, "reference 5": 1, "reference 6": 1, "reference 7": 1, "reference 1": 1, "reference 2": 1, "case presentation": 1, "statistics": 1, "conflict of interest": 1, "introduction": 24, "abbreviations": 1, "what is known about this topic": 1, "staging of serotonergic dysfunction in parkinsons disease": 1, "authors contributions": 58, "reference 8": 1, "inclusion criteria": 1, "patients and methods": 1, "supplementary data": 1, "appendix": 1, "gsk3 and morphology in fx mice": 1, "authors": 1, "role of gsk-3 in ltp and ltd": 1, "upstream regulation of gsk-3 in synaptic plasticity": 1, "exclusion criteria": 1, "involvement of cb1rs in neuropsychiatric disorders": 1, "serotonergic dysfunction and parkinsonsdisease symptomatology": 1, "financiacin": 1, "the neuroprotective actions of ghrelin and ghs": 1, "summary": 1, "future perspectives": 1, "electrocardiography": 1, "study limitations": 1, "methodsdesign": 9, "ethnicity definitions": 1, "abstract": 59, "qu se sabe sobre el tema": 1, "statistical analysis": 2, "direct and indirect regulation of gsk3 by lithium": 1, "reference 26": 1, "clinical trials": 1, "discussion": 65, "funding sources and potential conflicts of interest": 1, "amelioration of fxs-associated behavioral abnormalities by lithium and other gsk3 inhibitors": 1, "case reports": 1, "conclusion": 18, "materials and methods": 10, "qu aporta el estudio realizado a la literatura": 1, "a distinctive role of cannabidiol cbd in neuropsychiatric disorders": 1, "competing interests": 55, "recurrence and mortality rates": 1, "figure 1": 1, "acknowledgements": 48, "the ecb system and eating disorders toward a new therapeutically valid approach": 1, "cort and glutamate receptors": 1, "role in pathological synaptic plasticity": 1, "a brief update on the endocannabinoid ecb system": 1}
